ABI-009 (Nab-rapamycin) in Combination With FOLFOX and Bevacizumab as First-line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Condition: Colorectal Cancer Metastatic Intervention: Drug: ABI-009; nab-rapamycin; albumin-bound rapamycin Sponsor: Aadi, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials